METHAMPHETAMINE USE AND HSV-1 COINFECTION SYNERGISTICALLY ALTER IFN-Α, IFN-Γ, AND IL-29 EXPRESSION IN GINGIVAL CREVICULAR FLUID: IMPLICATIONS FOR GINGIVITIS PATHOGENESIS



Cite item

Full Text

Abstract

Background: Methamphetamine use compromises both innate and adaptive immune responses, substantially reducing the body’s ability to combat pathogens and preserve mucosal integrity. This immunosuppression heightens susceptibility to opportunistic infections such as herpes simplex virus type 1 (HSV-1), promotes viral reactivation, disrupts the balance and diversity of the oral microbiota, and accelerates inflammatory processes within oral tissues. As a result, it exacerbates a wide range of oral health problems, including gingivitis, periodontal disease, dental caries, oral mucosal lesions, and delayed wound healing within the oral cavity.

Aim: To investigate the levels of interferon-alpha (IFN-α), interferon-gamma (IFN-γ), and interleukin-29 (IL-29) in methamphetamine users with or without herpes simplex virus type 1 (HSV-1) infection, and to examine their association with the development of gingivitis.

Materials and Methods: This case-control study included 88 male participants aged 20–35 years, categorized into four groups: healthy controls, methamphetamine users, methamphetamine users with herpes simplex virus type 1 (HSV-1) infection, and patients with gingivitis. Gingival crevicular fluid (GCF) samples were collected from all participants, and the concentrations of interferon-alpha (IFN-α), interferon-gamma (IFN-γ), and interleukin-29 (IL-29) were measured using enzyme-linked immunosorbent assay (ELISA).

Results: Interferon-alpha (IFN-α) and interferon-gamma (IFN-γ) levels were highest in the healthy control group and were significantly reduced in the methamphetamine, methamphetamine with HSV-1, and gingivitis groups (p < 0.05). In contrast, interleukin-29 (IL-29) levels were significantly elevated in gingivitis patients compared to all other groups. Furthermore, methamphetamine users with HSV-1 infection exhibited markedly higher IL-29 concentrations than methamphetamine users without HSV-1 infection.

Conclusion: Methamphetamine use and HSV-1 infection significantly impair immune cytokine responses, reflected by marked reductions in interferon-alpha (IFN-α) and interferon-gamma (IFN-γ) levels, alongside elevated interleukin-29 (IL-29). The pronounced increase in IL-29 was most evident in gingivitis patients, suggesting a potential role for this cytokine in amplifying local inflammatory processes and contributing to periodontal tissue breakdown.

About the authors

Nazar Abdul Alsattar

University of Baghdad, Baghdad, Iraq

Email: Nezar.abd2407m@codental.uobaghdad.edu.iq

B.D.S, M.Sc., Oral Microbiology/ Oral Immunology

Lecturer;

Department of Basic Sciences, College of Dentistry, University of Baghdad, Baghdad, Iraq

Ирак

Ghada Ibrahim Taha

University of Baghdad, Baghdad, Iraq

Author for correspondence.
Email: ghada_ibraheem@codental.uobaghdad.edu.iq
ORCID iD: 0000-0002-1958-1939

B.Sc., M.Sc., Ph.D.  Microbiology / Clinical Immunology,

Assistant Professor;

Department of Basic Sciences, College of Dentistry, University of Baghdad, Baghdad, Iraq

Ирак

References

  1. Abdolvahab, M. H., Darvishi, B., Zarei, M., Majidzadeh-A, K., & Farahmand, L. (2020). Interferons: role in cancer therapy. Immunotherapy, 12(11), 833–855. https://doi.org/10.2217/imt-2019-0217
  2. Akasaki, Y., & Ohishi, M. (2020). Cerebrovascular and cardiovascular diseases caused by drugs of abuse. Hypertension Research, 43(5), 363–371. https://doi.org/10.1038/s41440-019-0367-7
  3. Alwan, A. H. (2024). The Impact of Age and Gender on Periodontal Conditions in Iraqi People: A Retrospective Study. Al-Rafidain Journal of Medical Sciences, 7(2), 38–42. https://doi.org/10.54133/ajms.v7i2.1364
  4. Bigley, N. J. (2014). Complexity of Interferon-γ Interactions with HSV-1. Frontiers in Immunology, 5. https://doi.org/10.3389/fimmu.2014.00015
  5. Borgmann, K., & Ghorpade, A. (2015). HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Frontiers in Microbiology, 6. https://doi.org/10.3389/fmicb.2015.01143
  6. Buño, I. J., Huff, J. C., Weston, W. L., Cook, D. T., & Brice, S. L. (1998). Elevated Levels of Interferon Gamma, Tumor Necrosis Factor α, Interleukins 2, 4, and 5, but Not Interleukin 10, Are Present in Recurrent Aphthous Stomatitis. Archives of Dermatology, 134(7). https://doi.org/10.1001/archderm.134.7.827
  7. de Menezes, S. A. F., de Araújo, V. C., Napimoga, M. H., de Alencar Menezes, T. O., Nogueira, B. M. L., de Souza Fonseca, R. R., & Martinez, E. F. (2018). Interleukin-6 and Interferon-α Levels in gingival crevicular fluid in HIV-1 patients with chronic periodontitis. International Journal of Odontostomatology, 12(3), 219–224.
  8. https://www.sidalc.net/search/Record/oai:scielo:S0718-381X2018000300219/Description
  9. Dominic, P., Ahmad, J., Awwab, H., Bhuiyan, Md. S., Kevil, C. G., Goeders, N. E., Murnane, K. S., Patterson, J. C., Sandau, K. E., Gopinathannair, R., & Olshansky, B. (2022). Stimulant Drugs of Abuse and Cardiac Arrhythmias. Circulation: Arrhythmia and Electrophysiology, 15(1). https://doi.org/10.1161/CIRCEP.121.010273
  10. Fatahzadeh, M., & Schwartz, R. A. (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737–763. https://doi.org/10.1016/j.jaad.2007.06.027
  11. Ghallab, N. A., El-Wakeel, N., & Shaker, O. G. (2010). Levels of Salivary IFN-gamma, TNF-Alfa, and TNF Receptor-2 As Prognostic Markers in (Erosive) Oral Lichen Planus. Mediators of Inflammation, 2010, 1–7. https://doi.org/10.1155/2010/847632
  12. Jasim, S. S., & Taha, G. I. (2023). Role of type III Interferon (IL-29) on HSV-1 infection in breast cancer patients suffering from periodontitis and receiving chemotherapy. Iranian Journal of Breast Diseases, 16(1), 85–95.
  13. http://dx.doi.org/10.30699/ijbd.16.1.85
  14. Kelm, N. E., Zhu, Z., Ding, V. A., Xiao, H., Wakefield, M. R., Bai, Q., & Fang, Y. (2016). The role of IL-29 in immunity and cancer. Critical Reviews in Oncology/Hematology, 106, 91–98. https://doi.org/10.1016/j.critrevonc.2016.08.002
  15. Kevil, C. G., Goeders, N. E., Woolard, M. D., Bhuiyan, Md. S., Dominic, P., Kolluru, G. K., Arnold, C. L., Traylor, J. G., & Orr, A. W. (2019). Methamphetamine Use and Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(9), 1739–1746. https://doi.org/10.1161/ATVBAHA.119.312461
  16. Kinane, D. F., Stathopoulou, P. G., & Papapanou, P. N. (2017). Periodontal diseases. Nature Reviews Disease Primers, 3(1), 17038. https://doi.org/10.1038/nrdp.2017.38
  17. Lazear, H. M., Nice, T. J., & Diamond, M. S. (2015). Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity, 43(1), 15–28. https://doi.org/10.1016/j.immuni.2015.07.001
  18. Le Moal, M., & Koob, G. F. (2007). Drug addiction: Pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology, 17(6–7), 377–393. https://doi.org/10.1016/j.euroneuro.2006.10.006
  19. Lee, H. H., Sudhakara, P., Desai, S., Miranda, K., & Martinez, L. R. (2021). Understanding the Basis of METH Mouth Using a Rodent Model of Methamphetamine Injection, Sugar Consumption, and Streptococcus mutans Infection. MBio, 12(2). https://doi.org/10.1128/mBio.03534-20
  20. Liang, H., Wang, X., Chen, H., Song, L., Ye, L., Wang, S.-H., Wang, Y.-J., Zhou, L., & Ho, W.-Z. (2008). Methamphetamine Enhances HIV Infection of Macrophages. The American Journal of Pathology, 172(6), 1617–1624. https://doi.org/10.2353/ajpath.2008.070971
  21. Mathur, A., Michalowicz, B., Castillo, M., & Aeppll, D. (1996). Interleukin‐1 alpha, interleukin‐8 and interferon‐alpha levels in gingival crevicular fluid. Journal of Periodontal Research, 31(7), 489–495. https://doi.org/10.1111/j.1600-0765.1996.tb01414.x
  22. Mohammad, B. S., & Taha, G. I. (2024). The Role of Ramadan Fasting on Secretory IgA and Statherin Levels in Individuals with Dental Caries. Journal of the Faculty of Medicine Baghdad, 66(2), 230–236. https://doi.org/10.32007/jfacmedbagdad.662225
  23. Mohammad, B. S., & Taha, G. I. (2025). The Impact of Ramadan Fasting on Oral Health Biomarkers Linked to Dental Caries. AL-Kindy College Medical Journal, 21(1), 47–52. https://doi.org/10.47723/f45wj039
  24. Muqarab, M., Gandapur, T. S., ul Ala, A., Yaseen, S., & Akbar, B. (2024). Prevalence Of Periodontal Diseases (Gingivitis, Periodontitis) among the Adult’s Patient Visiting to Dental Section of District Headquarter (DHQ) Hospital, Landikotal, Khyber Pakhtunkhwa, Pakistan. Journal of Rehman College of Dentistry, 5(1).
  25. https://jrcd.pk/index.php/jrcd/article/view/92
  26. Neurath, N., & Kesting, M. (2024). Cytokines in gingivitis and periodontitis: from pathogenesis to therapeutic targets. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1435054
  27. Passaro, R. C., Pandhare, J., Qian, H.-Z., & Dash, C. (2015). The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. Journal of Neuroimmune Pharmacology, 10(3), 477–486. https://doi.org/10.1007/s11481-015-9604-2
  28. Potula, R., Haldar, B., Cenna, J. M., Sriram, U., & Fan, S. (2018). Methamphetamine alters T cell cycle entry and progression: role in immune dysfunction. Cell Death Discovery, 4(1), 44. https://doi.org/10.1038/s41420-018-0045-6
  29. Robinson, T. E., & Kolb, B. (2004). Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology, 47, 33–46. https://doi.org/10.1016/j.neuropharm.2004.06.025
  30. Sainz, B., & Halford, W. P. (2002). Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1. Journal of Virology, 76(22), 11541–11550. https://doi.org/10.1128/JVI.76.22.11541-11550.2002
  31. Salahuddin Jasim, S., & Ghada Ibrahim Taha. (2023). Comparison between HSV-1 Ag detection techniques by ELISA and real-time PCR in breast cancer patients suffering from periodontitis. Journal of the Faculty of Medicine Baghdad, 65(3), 227–233. https://doi.org/10.32007/jfacmedbagdad.2105
  32. Salamanca, S. A., Sorrentino, E. E., Nosanchuk, J. D., & Martinez, L. R. (2015). Impact of methamphetamine on infection and immunity. Frontiers in Neuroscience, 8. https://doi.org/10.3389/fnins.2014.00445
  33. Sheibak, N., Heidari, Z., & Mahmoudzadeh-Sagheb, H. (2022). Immunoexpression of interferon-gamma in the interdental gingiva of chronic periodontitis patients with interferon-gamma (+874A/T) rs62559044 polymorphism. Journal of Oral Biology and Craniofacial Research, 12(5), 727–732. https://doi.org/10.1016/j.jobcr.2022.08.019
  34. Shetty, V., Harrell, L., Murphy, D. A., Vitero, S., Gutierrez, A., Belin, T. R., Dye, B. A., & Spolsky, V. W. (2015). Dental disease patterns in methamphetamine users. The Journal of the American Dental Association, 146(12), 875–885. https://doi.org/10.1016/j.adaj.2015.09.012
  35. Shivaprasad, B. M., & Pradeep, A. R. (2013). Effect of non-surgical periodontal therapy on interleukin-29 levels in gingival crevicular fluid of chronic periodontitis and aggressive periodontitis patients. Disease Markers, 34(1), 1–7. https://doi.org/10.3233/DMA-2012-120944
  36. Shivaprasad, B. M., & Pradeep, A. R. (2015). Correlation of the interleukin-29 levels in crevicular fluid and plasma with the genetic polymorphism in chronic and aggressive periodontitis patients. Archives of Oral Biology, 60(1), 37–44. https://doi.org/10.1016/j.archoralbio.2014.08.017
  37. Singh, J., & Gupta, P. K. (2017). Drug Addiction: Current Trends and Management. International Journal of Indian Psychology, 5(1). https://doi.org/10.25215/0501.057
  38. Tabari, Z. A., Hematzadeh, S., & Keshani, F. (2021). IL29 expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dental Research Journal, 18, 66.
  39. doi: 10.4103/1735-3327.324025
  40. TAHA, G. I. (2024). Involvement of IL-10 gene polymorphism (rs1800896) and IL-10 level in the development of periimplantitis. Minerva Dental and Oral Science, 73(5), 264–271. https://doi.org/10.23736/S2724-6329.23.04844-1
  41. Taha, G. I., Talib, E. Q., Abed, F. B., & Hasan, I. A. (2024). A review of microbial pathogens and diagnostic techniques in children’s oral health. Sri Lanka Journal of Child Health, 53(4), 355–359. https://doi.org/10.4038/sljch.v53i4.11043
  42. Talib, E. Q., & Taha, G. I. (2024). Involvement of interlukin-17A (IL-17A) gene polymorphism and interlukin-23 (IL-23) level in the development of peri-implantitis. BDJ Open, 10(1), 12. https://doi.org/10.1038/s41405-024-00193-9
  43. Tognarelli, E. I., Palomino, T. F., Corrales, N., Bueno, S. M., Kalergis, A. M., & González, P. A. (2019). Herpes Simplex Virus Evasion of Early Host Antiviral Responses. Frontiers in Cellular and Infection Microbiology, 9. https://doi.org/10.3389/fcimb.2019.00127
  44. Valencia, F., Bubar, M. J., Milligan, G., Cunningham, K. A., & Bourne, N. (2012). Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model. Sexually Transmitted Diseases, 39(9), 720–725.
  45. doi: 10.1097/OLQ.0b013e31825af129
  46. Wang, J., Huang, A., Xu, W., & Su, L. (2019). Insights into IL‐29: Emerging role in inflammatory autoimmune diseases. Journal of Cellular and Molecular Medicine, 23(12), 7926–7932. https://doi.org/10.1111/jcmm.14697
  47. Yang, X., Zhao, H., Liu, X., Xie, Q., Zhou, X., Deng, Q., & Wang, G. (2020). The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients. Frontiers in Psychiatry, 11 https://doi.org/10.3389/fpsyt.2020.594766
  48. Zanoni, I., Granucci, F., & Broggi, A. (2017). Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs. Frontiers in Immunology, 8. https://doi.org/10.3389/fimmu.2017.01661
  49. Zhou, L., Li, J., Wang, X., Ye, L., Hou, W., Ho, J., Li, H., & Ho, W. (2011). IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons. Journal of NeuroVirology, 17(3), 212–219. https://doi.org/10.1007/s13365-011-0031-8

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Alsattar N.A., Taha G.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies